Corona Virus

Tensions rise as FDA advisory panel weighs evidence on Pfizer booster

The FDA panel will vote Friday afternoon about whether to recommend the Pfizer-BioNTech booster for people 16 and older at least six months after their initial vaccination.Read More

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top